Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis

Transcatheter aortic valve implantation (TAVI) performed using femoral arterial access is now a guideline recommended treatment for severe calcific aortic stenosis (AS) in elderly patients. Technological advancements and procedural refinements have focused on making TAVI simpler, safer, more effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Seth, Ashok, Kumar, Vijay, Singh, Vivudh Pratap, Kumar, Dhananjay, Varma, Puneet, Rastogi, Vishal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2023
Materias:
Structural
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311401/
https://www.ncbi.nlm.nih.gov/pubmed/37398875
http://dx.doi.org/10.15420/icr.2020.32
_version_ 1785066732632670208
author Seth, Ashok
Kumar, Vijay
Singh, Vivudh Pratap
Kumar, Dhananjay
Varma, Puneet
Rastogi, Vishal
author_facet Seth, Ashok
Kumar, Vijay
Singh, Vivudh Pratap
Kumar, Dhananjay
Varma, Puneet
Rastogi, Vishal
author_sort Seth, Ashok
collection PubMed
description Transcatheter aortic valve implantation (TAVI) performed using femoral arterial access is now a guideline recommended treatment for severe calcific aortic stenosis (AS) in elderly patients. Technological advancements and procedural refinements have focused on making TAVI simpler, safer, more effective and durable. Myval (Meril Lifesciences) is a new generation balloon-expandable transcatheter heart valve (THV) developed in India that possesses novel features to improve deliverability and aid precise deployment. Following the first-in-human study, Myval was approved in India for commercial implantation in October 2018 and was subsequently given a CE mark in April 2019. This article reviews the science, technology and up-to-date clinical evidence for the Myval THV.
format Online
Article
Text
id pubmed-10311401
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-103114012023-07-01 Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis Seth, Ashok Kumar, Vijay Singh, Vivudh Pratap Kumar, Dhananjay Varma, Puneet Rastogi, Vishal Interv Cardiol Structural Transcatheter aortic valve implantation (TAVI) performed using femoral arterial access is now a guideline recommended treatment for severe calcific aortic stenosis (AS) in elderly patients. Technological advancements and procedural refinements have focused on making TAVI simpler, safer, more effective and durable. Myval (Meril Lifesciences) is a new generation balloon-expandable transcatheter heart valve (THV) developed in India that possesses novel features to improve deliverability and aid precise deployment. Following the first-in-human study, Myval was approved in India for commercial implantation in October 2018 and was subsequently given a CE mark in April 2019. This article reviews the science, technology and up-to-date clinical evidence for the Myval THV. Radcliffe Cardiology 2023-04-10 /pmc/articles/PMC10311401/ /pubmed/37398875 http://dx.doi.org/10.15420/icr.2020.32 Text en Copyright © 2023, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Structural
Seth, Ashok
Kumar, Vijay
Singh, Vivudh Pratap
Kumar, Dhananjay
Varma, Puneet
Rastogi, Vishal
Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis
title Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis
title_full Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis
title_fullStr Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis
title_full_unstemmed Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis
title_short Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis
title_sort myval: a novel transcatheter heart valve for the treatment of severe aortic stenosis
topic Structural
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311401/
https://www.ncbi.nlm.nih.gov/pubmed/37398875
http://dx.doi.org/10.15420/icr.2020.32
work_keys_str_mv AT sethashok myvalanoveltranscatheterheartvalveforthetreatmentofsevereaorticstenosis
AT kumarvijay myvalanoveltranscatheterheartvalveforthetreatmentofsevereaorticstenosis
AT singhvivudhpratap myvalanoveltranscatheterheartvalveforthetreatmentofsevereaorticstenosis
AT kumardhananjay myvalanoveltranscatheterheartvalveforthetreatmentofsevereaorticstenosis
AT varmapuneet myvalanoveltranscatheterheartvalveforthetreatmentofsevereaorticstenosis
AT rastogivishal myvalanoveltranscatheterheartvalveforthetreatmentofsevereaorticstenosis

Ejemplares similares